Neurotrophic factors comprise a broad family of biomolecules–most of which are peptides or small proteins–that support the growth, survival and differentiation of both developing and …
J Samario-Román, C Larqué, P Pánico… - International journal of …, 2023 - mdpi.com
Nerve growth factor (NGF) was the first neurotrophin described. This neurotrophin contributes to organogenesis by promoting sensory innervation and angiogenesis in the …
N Xiao, QT Le - Archivum immunologiae et therapiae experimentalis, 2016 - Springer
Neurotrophic factors are growth factors that can nourish neurons and promote neuron survival and regeneration. They have been studied as potential drug candidates for treating …
J Houtz, P Borden, A Ceasrine, L Minichiello… - Developmental cell, 2016 - cell.com
Insulin secretion by pancreatic islet β cells is critical for glucose homeostasis, and a blunted β cell secretory response is an early deficit in type 2 diabetes. Here, we uncover a regulatory …
A Gaceb, M Barbariga, I Özen, G Paul - Biochimie, 2018 - Elsevier
Personalized and regenerative medicine is an emerging therapeutic strategy that is based on cell biology and biomedical engineering used to develop biological substitutes to …
H Tsuchiya, N Sakata, G Yoshimatsu, M Fukase… - PloS one, 2015 - journals.plos.org
Background The efficacy of intramuscular islet transplantation is poor despite being technically simple, safe, and associated with reduced rates of severe complications. We …
SL Cao, HY Luo, YC Gao, XM Lan, SY Liu… - Frontiers in Cell and …, 2022 - frontiersin.org
Diabetic nephropathy (DN) is one of the leading causes of chronic kidney disease (CKD), during which hyperglycemia is composed of the major force for the deterioration to end …
KE Smith, AC Kelly, CG Min, CS Weber… - …, 2017 - journals.lww.com
Background Encapsulation devices have the potential to enable cell-based insulin replacement therapies (such as human islet or stem cell–derived β cell transplantation) …
A Sobuś, B Baumert, Z Litwińska… - International journal of …, 2018 - mdpi.com
Therapeutic options for amyotrophic lateral sclerosis (ALS) are still limited. Great hopes, however, are placed in growth factors that show neuroprotective abilities (eg, nerve growth …